The Truth Gender Clinicians Tried to Ignore - Dr Susan Bradley (#43)
Dr. Susan Bradley spent nearly five decades treating gender-dysphoric children in Toronto and chaired the DSM-IV sub-committee on gender identity. In this episode she explains what she believes went catastrophically wrong — and her testimony lands with particular force in Europe, where the Dutch Protocol she critiques was exported across the continent, underpinning gender clinics from Amsterdam to Stockholm and beyond before the evidence began to unravel. She speaks about puberty blockers, autism, the silencing of dissenting clinicians, and a career's worth of children who mostly turned out to be gay or lesbian.
Dr. Susan Bradley is not a commentator or an activist. She is one of the architects of paediatric gender medicine in North America, having co-founded Toronto's first specialist clinic in 1975 and gone on to treat more than four hundred gender-dysphoric children across the following decades. She also chaired the DSM-IV sub-committee that defined gender identity disorder. When someone with those credentials says the field went catastrophically wrong, it is not an ideological claim. It is an insider admission of the first order. The episode's most striking thread for European listeners is Bradley's judgment on puberty blockers. The Dutch Protocol — developed in Amsterdam in the 1990s and subsequently adopted across Sweden, Finland, Belgium, the Netherlands and beyond — was built on the promise that hormonal suppression was reversible, a neutral pause while young people considered their options. Bradley rejects that framing entirely. She does not believe blockers are reversible, and she observes that roughly ninety per cent of children who begin them progress to cross-sex hormones. This is not a pause button. It is a pipeline with near-certain outcomes built in from the very start, and it was the Dutch model, not some later American excess, that established that pathway. A second issue with direct clinical relevance for European practitioners is the overlap between gender dysphoria and autism spectrum conditions. Research suggests that trans-identified adults are between three and six times more likely to be autistic than the general population. Bradley draws on decades of clinical observation to argue that autistic young people, once they have found a framework that seems to explain their distress, hold to it with particular tenacity — which makes exploratory, unhurried psychotherapeutic work both more necessary and considerably harder to sustain under current affirmative-care protocols. Bradley also shares what she found, again and again, across her career: that the great majority of gender-dysphoric children seen in her clinic eventually came to identify as gay or lesbian. She illustrates this with a patient called Frankie, who arrived at nine years old convinced he wanted to be a girl, found his way to a gay youth group, fell for someone, and let the dysphoria go. This outcome — common in the pre-affirmation era — is precisely what watchful waiting and psychotherapy were designed to allow. The move away from that approach has foreclosed it for a generation of children. The episode also addresses the firing of Dr. Kenneth Zucker from the Centre for Addiction and Mental Health in 2015, an event that sent a chilling signal to clinicians internationally. Accused of practising conversion therapy, Zucker was removed from his post; CAMH later apologised and paid a substantial settlement. European clinicians who attempted to slow or question affirmative protocols faced comparable professional risks throughout the same period. Bradley's willingness to name what happened — and to say plainly that the field knew, and suppressed what it knew — carries weight precisely because of her standing within that field. For those following policy across the continent — from the restrictions already enacted in Sweden and Finland to active debates in France, Germany and at EU level — Bradley's testimony adds to a body of expert dissent that is no longer possible to dismiss as fringe. The question that lingers after this conversation is not whether serious mistakes were made. It is how health systems that adopted these protocols without adequate long-term evidence now account for that to the young people involved.
